首页> 中文期刊> 《中国卫生标准管理》 >卵磷脂络合碘在玻璃体出血治疗中的应用研究

卵磷脂络合碘在玻璃体出血治疗中的应用研究

             

摘要

Objective Jolethin application and its clinical effect in treatment of vitreous hemorrhage are to be analyzed. Methods Choose 40 patients of vitreous hemorrhage who are treated in hospital from March 2014 to December 2014 and separate them into two groups at random,one group is given carbazochrome and xuesetong tablet treatment and the other group is given jolethin treatment;and then compare treatment effects between two groups. Results Treatment efficacy in control group and study group are 75% and 95% respectively; and side-effect incidence are 25% and 5% respectively, there is a treatment differential between two groups,and such a differential has statistic value(P<0.05).Conclusion Jolethin application is of clinical effect in treatment of vitreous hemorrhage; it is effective to cure vitreous hemorrhage resulted from various reasons and reduce side-effect incidence, thus,jolethin is of clinical application value in treatment of vitreous hemorrhage.%目的:对卵磷脂络合碘在玻璃体出血治疗中的应用以及临床效果进行分析。方法选取于2014年3月~2014年12月在我院眼科接受治疗的40例玻璃体出血患者随机分成两组对卡巴克洛、血塞通片和卵磷脂络合碘的临床治疗效果进行对照研究。结果对照组和治疗组的治疗总有效率分别为75%和95%,不良反应发生率分别为25%和5%,两组结果对比差异显著,有统计学意义(P<0.05)。结论采用卵磷脂络合碘治疗玻璃体出血具有显著的临床疗效,不仅能够治疗各种原因造成的玻璃体出血,而且还能显著降低不良反应的发生,对治疗玻璃体出血有着重要的临床应用价值。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号